2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Pancreatic Neoplasms
7
Breast Neoplasms
5
Radiation Fibrosis Syndrome
3
Pancreatic Adenocarcinoma
2
Lung Neoplasms
2
Glioblastoma
2
Thrombocytosis
1
Stomatitis
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Peripheral Nervous System Diseases
1
Pancreatic Ductal Adenocarcinoma
1
Osteosarcoma
1
Neuroma, Acoustic
1
Neoplasms
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Interventions
Amiodarone
3
Standard of Care
1
Sodium Chloride
1
Metoprolol
1
Mass Screening
1
Losartan
1
Heparin, Low-Molecular-Weight
1
Gonadal Steroid Hormones
1
Electrocardiography
1
Diagnosis
1
Cardiac Surgical Procedures
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Atrial Fibrillation
×
Losartan
×
Clear all
NCT01281787
2014-06-18
PRESAGE
European Institute of Oncology
Phase 3
Completed
320 enrolled